Anti-human CD47 monoclonal antibody, magrolimab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1037-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: Hu5F9-G4
target CD47
alias CD47, MER6, IAP
gene id Uniprot ID: Q08722
host species Chimeric Humanized
reactivity Human
iso type Human IgG4 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

HEK293 cell line transfected with irrelevant protein (B) and human CD47 (A) were surface stained with anti-CD47 neutralizing antibody 1ug/ml (magrolimab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human CD47, mFc-His tagged protein binds to Anti-CD47 (Neutralizing antibody clone Hu5F9-G4) in a linear range of 0.061-1.606 ng/ml.


PRODUCT

  • SKU

    DMS1037-100ug

  • Size

    100ug

  • Price

    $350

1